Richard Brodsky, M.S.
Richard currently serves as the Head of Rare Disease Commercial Strategy for Augur Health. Recently, he has completed the successful neurology development, and launch of a rare disease drug for Myasthenia Gravis. Prior to Augur, he worked for more than 20 years in the pharmaceutical industry serving roles as Director of New Business for Pfizer and Global Neurology Marketing Leader for Alexion Pharmaceuticals. Richard has extensive experience as a senior business leader, specifically in new product development and launch, marketing, business operations, business development, and finance.